Arthroplasty following a septic arthritis history: A 53 cases series  by Bauer, T. et al.
OO
A
A
T
A
a
9
b
1
1
drthopaedics & Traumatology: Surgery & Research (2010) 96, 840—843
RIGINAL ARTICLE
rthroplasty following a septic arthritis history:
53 cases series
. Bauera,∗, S. Lacostea, L. Lhotellierb, P. Mamoudyb,
. Lortat-Jacoba, P. Hardya
Orthopedic and Traumatological Surgery Department, Ambroise-Paré Hospital, West Paris-Île-de-France University,
, avenue Charles-de-Gaulle, 92100 Boulogne, France
Orthopedic and Traumatological Surgery Department, Diaconesses Hospital Group, Croix Saint-Simon,
25, rue d’Avron, 75020 Paris, France
Accepted: 1st June 2010
KEYWORDS
Septic arthritis;
Arthroplasty;
Staphylococcus
Summary
Introduction: The most feared complication of arthroplasty after septic arthritis (active or
quiescent) on a degenerative joint is septic failure, but this risk is difﬁcult to assess. The aim
of the present study was to analyze the results of arthroplasties after septic arthritis of native
knee and hip joints, in terms of functional results and infection control and to seek eventual
risk factors of failure.
Patients and methods: Fifty-three cases of septic arthritis treated by arthroplasty (31 knees
and 22 hips) were retrospectively included. In case of evolutive septic arthritis (30 cases: 17
knees and 13 hips) failing to react to conservative treatment, arthroplasty was performed in
a 2-stage procedure (a mean interval of 6 weeks between stages, and an associated antibiotic
therapy for a mean 3 months were routinely respected). In case of previous arthritis considered
to be cured (23 cases: 14 knees and nine hips), arthroplasty was performed with a 1-stage
procedure, observing a mean interval of 5 years after the initial septic arthritis, and antibiotic
therapy maintained until deﬁnitive microbiological results were obtained from joint cultures
samples at surgery. No patients were lost to follow-up; minimum follow-up was 2 years, for
a mean of 5 years. The ﬁnal results were assessed in terms of functional outcome (on PMA
functional score for hips and IKS score for knees) and successful eradication of infection.
Results: Two-stage arthroplasty was successful in 26 of the 30 cases of evolutive septic arthri-
tis (87%), while the 1-stage procedure was successful in 22 of the 23 cases of quiescent septic
arthritis (95%) (NS). Functional results were very good. No signiﬁcant difference in functional
outcome or successful eradication of infection was found between the 1- and 2-stage proce-
dures. No signiﬁcant difference in ﬁnal outcome in terms of infection eradication was found
between knees and hips. No clinical, microbiological or treatment-related criteria emerged as
risk factors for septic failure.
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Discussion: Arthroplasty after septic arthritis of the knee or hip using the present protocol
(2-stage implantation in case of evolutive septic arthritis and a 1-stage procedure in case of
quiescent septic arthritis) achieved very good functional results with a success rate of 87% for
sepsis control in evolutive septic arthritis and of 95% in quiescent septic arthritis.
Level of evidence: Level IV retrospective or historical series.
© 2010 Elsevier Masson SAS. All rights reserved.
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atically taken before arthroplasty. Total joint replacement,
with associated synovectomy, was performed in a 1-stage
procedure, at a mean 5 years after the initial septic episode
(range, 2—18 years). All cases of previous septic arthri-
tis lacking microbiological data were excluded to improve
inter-group comparison. Five deep samples (synovial and
bone tissue) were systematically taken. The microbiological
Table 1 Clinical and microbiological characteristics of ini-
tial septic arthritis.
Knee Hip
n 31 22
Mean age 57 (31—82) 60 (29—92)
Origin of infection
Postoperative 15 12
Hematogenous 10 10
Secondary to inﬁltration 6
Arthritis status
Evolutive 17 13
Considered resolved 14 9
Pre-operative microbiology
S. aureus 10 9
Coagulase-negative S. 8 6
Streptococcus 6 3
GNB 4 2Introduction
Management of septic arthritis in its initial stage is medico-
surgical, treatment strategy being guided by microbiological
and imaging data and symptom evolution [1,2]. When sep-
tic arthritis with bone involvement, management comprises
not only antibiotic therapy but more aggressive surgery asso-
ciating total synovectomy and joint resection, classically
followed by either arthrodesis (particularly in the knee) or
resection arthroplasty or coaptation (in the hip) [3—6]. The
role of arthroplasty in the management of septic arthritis
remains to be clearly deﬁned. Joint replacement provides
a much better functional result than arthrodesis or resec-
tion arthroplasty, but incurs a risk of septic failure, which
is difﬁcult to assess. Moreover, in case of previous joint
infection quiescent for long enough to be considered to be
resolved, onset of functional joint deterioration raises the
question of degenerative joint pathology or late resurgence
of infection [7]. The role of arthroplasty and treatment
strategy as a whole (pre-operative assessment, 1- or 2-stage
surgery, antibioprophylaxis, postoperative antibiotic ther-
apy and follow-up) in this situation of doubt are not clearly
established.
The prime objective of the present study was to assess
infection results in arthroplasty for septic arthritis of the
native knee or hip. Secondary objectives were to highlight
clinical, microbiological and treatment-related risk factors
for failure.
Patients and methods
This 2-center continuous retrospective series included 53
cases of native joint infection (31 knees and 22 hips) man-
aged by arthroplasty (Table 1). All patients undergoing
arthroplasty, associated with either evolutive or quiescent
septic arthritis were included. Only septic arthritis impli-
cating pyogenic bacteria were included; those implicating
mycobacteria were excluded.
In evolutive septic arthritis (30 cases: 17 knees, 13 hips),
2-stage arthroplasty was performed in case of failure of
conservative medico-surgical treatment (joint lavage, syn-
ovectomy and drainage with associated adapted antibiotic
therapy) diagnosed from persistent clinical and biologi-
cal inﬂammatory syndrome, functional deterioration of the
affected joint, onset of radiological signs of cartilage and
especially bone involvement (evolutive joint-line narrow-
ing and appearance of areas of osteolysis or bone loss) and
persistence of microbiologically positive joint samples. The
ﬁrst stage comprised total synovectomy with joint resection
and insertion of a cement spacer without antibiotics. Fiveeep samples (synovial and bone tissue) were systematically
aken. The microbiological diagnosis of infection was estab-
ished in case of at least two out of ﬁve samples positive for
he same bacterium. The second stage, comprising repeated
ynovectomy and total joint replacement, was performed at
mean 6 weeks after step 1 (range, 4 weeks to 4 months).
mplantation was indicated essentially on microbiological
riteria once CRP assay became normal and stable for at
east 2 consecutive weeks. Antibiotic bi-therapy was associ-
ted for a mean 93 days (range, 45—180 days) following the
rst stage.
In previous septic arthritis considered to be resolved (23
ases: 14 knees, nine hips), arthroplasty was performed in
ase of functional deterioration in the affected joint. Septic
rthritis was considered as resolved on a range of criteria:
nterval of at least 2 years after treatment of the initial
nfection, absence of clinical or biological inﬂammatory
yndrome, and negative ﬁndings on the joint sample system-Polymicrobial 3 2
S. aureus: Staphylococcus aureus; coagulase-negative S.:
coagulase-negative Staphylococcus; GNB: Gram-negative
bacillus.
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iagnosis of infection was established in case of at least two
ut of ﬁve samples positive for the same bacterium. Antibi-
tic therapy adapted to the initially implicated bacterium
as initiated after intra-operative sampling and maintained
ntil deﬁnitive microbiological results were established. In
even of the 23 cases, the intra-operative sample was posi-
ive (at least two out of ﬁve samples positive for the same
acterium: Staphylococcus aureus in four cases, coagulase-
egative Staphylococcus in two, and Gram-negative bacillus
n one) and adapted antibiotic therapy was associated for a
ean 80 days (range, 45—120 days) after arthroplasty.
No patients were lost to follow-up; minimum follow-up
as 2 years, for a mean of 5 years (range, 2—13 years).
he ﬁnal results were assessed in terms of functional out-
ome (on Postel-Merle d’Aubigné [PMA] functional score [8]
or total hip replacement and International Knee Society
IKS] score [9] for total knee replacement) and eradi-
ation of infection. Resolution of infection was assessed
y absence of evolutive clinical or radiological syndrome
round the implant, absence of evolutive clinical or biologi-
al inﬂammatory syndrome, and absence of surgical revision
or infection.
Statistical analysis used Khi2 and analysis of variance
ANOVA) correlation tests.
esults
n 15 of the 17 cases of evolutive septic arthritis of the
nee managed by 2-stage arthroplasty (88%), infection was
ssessed as resolved at end of follow-up, with a mean IKS
nee score of 83/100 (range, 65—100) and mean IKS func-
ional score of 80/100 (range, 40—100). In 13 of the 14 cases
f quiescent septic arthritis of the knee managed by 1-stage
rthroplasty (93%), infection was assessed as resolved at
nd of follow-up, with a mean IKS knee score of 91/100
range, 75—100) and mean IKS functional score of 80/100
range, 45—100). In 11 of the 13 cases of evolutive sep-
ic arthritis of the hip managed by 2-stage arthroplasty
85%), infection was assessed as resolved at end of follow-
p, with a mean PMA score of 16.5/18 (14—18). In all nine
ases of quiescent septic arthritis of the hip managed by
- stage arthroplasty, infection was assessed as resolved at
nd of follow-up, with a mean PMA score of 17.5/18 (range,
6—18). No signiﬁcant difference emerged in terms of infec-
ion control or functional result at end of follow-up between
-stage joint replacement for evolutive septic arthritis and
-stage joint replacement for quiescent septic arthritis, or
etween arthroplasty for septic arthritis of the knee versus
he hip in terms of infection control.
Infection was eradicated in 26 of the 30 cases of evolu-
ive septic arthritis of the knee or hip managed by 2-stage
rthroplasty (87%), and in 22 of the 23 cases of quiescent
eptic arthritis managed by 1-stage arthroplasty (95%) (NS).
our cases of evolutive septic arthritis showed evolutive sep-
ic recurrence, implicating the same bacterium (S. aureus in
wo cases, coagulase-negative Staphylococcus in one case
nd Gram-negative bacillus in 1 case), at a mean 18 months
range, 8 month to 1 year). Only one case of quiescent sep-
ic arthritis showed evolutive septic recurrence (implicating
. aureus), at 30 months after arthroplasty. Of the 23 cases
f quiescent septic arthritis managed by 1-stage arthro-
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lasty, the seven with positive intra-operative samples were
ree of recurrence of infection at end of follow-up.
No clinical (location, arthritis status as evolutive or
uiescent considered to be resolved, or interval between
nfection and arthroplasty), microbiological (bacterium, or
ositive intra-operative samples in case of quiescent septic
rthritis considered to be resolved) or treatment-related cri-
eria (1- vs. 2-stage implantation, or duration of antibiotic
herapy) emerged as a risk factor for failure of management
f septic arthritis by arthroplasty.
iscussion
anagement of septic arthritis by arthroplasty using the
resent protocol (2-stage total joint replacement in case
f evolutive arthritis and 1-stage total joint replacement in
ase of quiescent arthritis) gave very good functional results
n both knee and hip, with an infection control rate of 87%
n evolutive septic arthritis and of 95% in quiescent arthritis
NS).
Arthrodesis or joint resection are classically recom-
ended in evolutive septic native joint arthritis with osseous
nvolvement and in sequelae of quiescent infantile or adult
eptic arthritis considered to be resolved, whatever the
mplicated bacterium (pyogenic or mycobacterium). The
ole of arthroplasty in such indications remains to be clearly
eﬁned, and there is a risk of complications and especially
f failure due to infection (by peroperative contamination
n evolutive septic arthritis, or by resurgence of quiescent
eptic arthritis) which is difﬁcult to assess [4—6,10,11].
In quiescent septic arthritis, resolution of infection
emains uncertain even after several years free of symp-
oms. Pre-operative joint biopsy is mandatory to screen for
ny low-level background infection, but the rate of false
egatives is high (seven out of 23 in the present series).
ntra-operative deep samples (joint ﬂuid, synovial tissue,
one section) are thus required: they may either conﬁrm
he absence of evolutive osteoarticular infection or, on the
ontrary, detect bacteria despite negative pre-operative
iopsy results [7,12—14]. Given this possibility, arthroplasty
n quiescent septic arthritis considered to be resolved should
nclude total synovectomy and associated antibiotic therapy
dapted to the bacteria implicated in the initial infection (if
uch microbiological ﬁndings are available). The antibiotic
herapy should be initiated after intra-operative deep sam-
ling and maintained until deﬁnitive results are obtained
n late culture, and be adapted to any bacteria identi-
ed intra-operatively. Standard antibioprophylaxis is thus
ot performed in these circumstances. Where initial micro-
iological data are lacking for quiescent septic arthritis,
he molecules of standard arthroplasty antibioprophylaxis
ay be prescribed, but with treatment beginning after
ntra-operative deep sampling and being maintained until
eﬁnitive results are obtained.
Arthroplasty to manage evolutive septic arthritis provides
7 to 100% resolution of infection, depending on the report,
lthough series were few and often small [4,8,15—18]. In
uiescent septic arthritis considered to be resolved, arthro-
lasty provides 90 to 100% resolution [6,7,11—13,15,19—21].
n the present series, treatment strategy depended on evo-
utivity as assessed on basically clinical, biological and
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microbiological criteria, with pre-operative biopsy in all
cases. Two-stage arthroplasty, applied in cases of evolutive
septic arthritis, provided resolution in 87% of cases, and
1-stage arthroplasty, applied in quiescent septic arthritis,
in 95%. According to several authors, however, arthro-
plasty, whether for evolutive or quiescent septic arthritis,
can be performed in a one stage procedure with results
comparable to those obtained with a 2-stage procedure
[7,10,12,13,15]. Our 2-stage joint replacement attitude was
mainly due to foreseeable difﬁculties of excision and the
uncertainty of microbiological ﬁndings in evolutive septic
arthritis despite various medico-surgical treatment modali-
ties. Positive ﬁndings from intra-operative samples despite
negative pre-operative biopsy did not seem to be risk fac-
tors for failure in infection control (no failure in terms of
infection control in the seven cases in the present series) as
long as the 1-stage joint replacement was performed as in
our protocol, with total synovectomy and associated antibi-
otic therapy maintained until the deﬁnitive microbiological
ﬁndings.
No risk factors for failure or arthroplasty to manage
septic arthritis emerged in the present study. From the liter-
ature, however, it would seem that comorbidity in the broad
sense (associated defects, immunodepression) is a factor of
increased risk of recurrence of infection following arthro-
plasty [11,13,22,23]. The stage of joint infection evolution
and the degree of bone involvement are certainly also to be
taken into account in assessing the risk of failure. Jerry et
al. [12] reported a 4% rate of recurrence of infection after
arthroplasty for simple septic arthritis and 15% for septic
arthritis with bone involvement. According to Kim et al. [21],
the longer the symptom-free interval between initial joint
infection and implantation, the higher the success rate.
The present study had certain limitations due to a sam-
ple size providing insufﬁcient statistical power. Moreover, it
was in some cases difﬁcult to specify quiescent septic arthri-
tis considered to be resolved on purely clinical, biological
and microbiological criteria. Scintigraphy and histological
and microbiological analysis with molecular biology of deep
samples might clarify criteria of success or failure of implan-
tation in these situations [24].
Conclusion
Management of septic arthritis by arthroplasty following
the present protocol (2-stage implantation in evolutive and
1-stage in quiescent arthritis) gave very good functional
results in both knee and hip, with 87% of eradication of infec-
tion in evolutive septic arthritis and 95% in quiescent septic
arthritis. No clinical, microbiological or treatment-related
risk factors for failure emerged.
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